Inovio Pharmaceuticals is a biotechnology business based in the US. Inovio Pharmaceuticals stocks (INO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $8.7 – a decrease of 9.88% over the previous week. Inovio Pharmaceuticals employs 262 staff and has a trailing 12-month revenue of around $6.5 million.
How to buy Inovio Pharmaceuticals stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: INO in this case.
- Research Inovio Pharmaceuticals stocks. The platform should provide the latest information available.
- Buy your Inovio Pharmaceuticals stocks. It's that simple.
Is it a good time to buy Inovio Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in Inovio Pharmaceuticals?
- Has coronavirus impacted Inovio Pharmaceuticals shares?
- Inovio Pharmaceuticals shares summary
- Compare share dealing platforms
- Is Inovio Pharmaceuticals stock a buy or sell?
- Inovio Pharmaceuticals performance over time
- Can I short Inovio Pharmaceuticals shares?
- Inovio Pharmaceuticals's financials
- How volatile are Inovio Pharmaceuticals shares?
- Does Inovio Pharmaceuticals pay a dividend?
- Have Inovio Pharmaceuticals shares ever split?
- Other common questions
How has Coronavirus impacted Inovio Pharmaceuticals's stock price?
Since the stock market crash in March caused by coronavirus, Inovio Pharmaceuticals's stock price has had significant positive movement.
Its last market close was $7.57, which is 50.53% up on its pre-crash value of $3.745 and 141.08% up on the lowest point reached during the March crash when the stocks fell as low as $3.14.
If you had bought $1,000 worth of Inovio Pharmaceuticals stocks at the start of February 2020, those stocks would have been worth $1,693.07 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,936.03.
Inovio Pharmaceuticals stock priceUse our graph to track the performance of INO stocks over time.
Inovio Pharmaceuticals stocks at a glance
|Latest market close||$7.57|
|52-week range||$5.81 - $19|
|50-day moving average||$8.5986|
|200-day moving average||$8.6266|
|Wall St. target price||$13.33|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.754|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Inovio Pharmaceuticals price performance over time
|1 week (2021-09-09)||-9.88%|
|1 month (2021-08-16)||-9.12%|
|3 months (2021-06-16)||-11.67%|
|6 months (2021-03-16)||-27.70%|
|1 year (2020-09-16)||-59.13%|
|2 years (2019-09-16)||181.41%|
|3 years (2018-09-14)||49.90%|
|5 years (2016-09-16)||-18.07%|
Inovio Pharmaceuticals financials
|Revenue TTM||USD$6.5 million|
|Gross profit TTM||USD$-86,834,216|
|Return on assets TTM||-24.33%|
|Return on equity TTM||-40.79%|
|Market capitalisation||USD$1.7 billion|
TTM: trailing 12 months
How to short and sell Inovio Pharmaceuticals stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "INO.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 42.6 million Inovio Pharmaceuticals stocks held short by investors – that's known as Inovio Pharmaceuticals's "short interest". This figure is 1.9% down from 43.4 million last month.
There are a few different ways that this level of interest in shorting Inovio Pharmaceuticals stocks can be evaluated.
Inovio Pharmaceuticals's "short interest ratio" (SIR)
Inovio Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Inovio Pharmaceuticals stocks currently shorted divided by the average quantity of Inovio Pharmaceuticals stocks traded daily (recently around 4.9 million). Inovio Pharmaceuticals's SIR currently stands at 8.63. In other words for every 100,000 Inovio Pharmaceuticals stocks traded daily on the market, roughly 8630 stocks are currently held short.
However Inovio Pharmaceuticals's short interest can also be evaluated against the total number of Inovio Pharmaceuticals stocks, or, against the total number of tradable Inovio Pharmaceuticals stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Inovio Pharmaceuticals's short interest could be expressed as 0.2% of the outstanding stocks (for every 100,000 Inovio Pharmaceuticals stocks in existence, roughly 200 stocks are currently held short) or 0.2057% of the tradable stocks (for every 100,000 tradable Inovio Pharmaceuticals stocks, roughly 206 stocks are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the stock price, with fewer people currently willing to bet against Inovio Pharmaceuticals.
Find out more about how you can short Inovio Pharmaceuticals stock.
Inovio Pharmaceuticals stock dividends
We're not expecting Inovio Pharmaceuticals to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Have Inovio Pharmaceuticals stocks ever split?
Inovio Pharmaceuticals stocks were split on a 1:4 basis on 6 June 2014. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Inovio Pharmaceuticals stocks – just the quantity. However, indirectly, the new 300% higher stock price could have impacted the market appetite for Inovio Pharmaceuticals stocks which in turn could have impacted Inovio Pharmaceuticals's stock price.
Inovio Pharmaceuticals stock price volatility
Over the last 12 months, Inovio Pharmaceuticals's stocks have ranged in value from as little as $5.81 up to $19. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inovio Pharmaceuticals's is 0.6206. This would suggest that Inovio Pharmaceuticals's stocks are less volatile than average (for this exchange).
Inovio Pharmaceuticals overview
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon optimized plasmids that have ability to help break the immune system's tolerance of cancerous or infected cells and facilitate cross-strain protection against unmatched and matched pathogen variants. The company is involved in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, including head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, such as recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); Lassa fever; Zika virus; and the COVID-19 virus (coronavirus). Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company also has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800, which is currently in Phase I clinical testing for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquart
Stocks similar to Inovio Pharmaceuticals
Inovio Pharmaceuticals in the news
First Week of January 2024 Options Trading For Inovio Pharmaceuticals (INO)
First Week of January 2024 Options Trading For Inovio Pharmaceuticals
Inovio Downgraded by BofA on Limited Covid Opportunity
Frequently asked questions
More on investing
Everything we know about the Amkor Technology IPO, plus information on how to buy in. Read more…
We look at 6 popular stock discussion groups from Canada and overseas.Read more…
We’ve rounded up the top dividend stocks in Canada. Check out current stock prices, historical stock performance, company info and more.Read more…
More guides on Finder
How to buy Planet Labs (PL) stock in Canada when it goes public
Everything we know about the Planet Labs IPO, plus information on how to buy in.
How to buy Impossible Foods stock in Canada when it goes public
Everything we know about the Impossible Foods IPO, plus information on how to buy in.
How to buy Samsara stock in Canada when it goes public
Everything we know about the Samsara IPO, plus information on how to buy in.
How to buy Allbirds (BIRD) stock in Canada when it goes public
Everything we know about the Allbirds IPO, plus information on how to buy in.
How to buy Smooth Love Potion (SLP) in Canada
This guide will show you step-by-step instructions on how to buy the Smooth Love Potion (SLP) token as well as a list of exchanges you can trade it on.
How to buy OnlyFans stock in Canada when it goes public
Everything we know about the OnlyFans IPO, plus information on how to buy in.
How to buy Vinco Ventures stock in Canada | $8.15
Ever wondered how to buy shares in Vinco Ventures? We explain how and compare a range of providers that can give you access to many brands, including Vinco Ventures.
How to buy Weber stock in Canada | $14.93
Steps to owning and managing Weber Inc. stocks, with 24-hour and historical pricing before you buy.
How to buy Chobani stock in Canada when it goes public
Everything we know about the Chobani IPO, plus information on how to buy in.
How to buy Quickswap (QUICK) in Canada
This guide will show you step-by-step instructions on how to buy the Quickswap (QUICK) token as well as a list of exchanges you can trade it on.